ILIOCAVAL THROMBOSIS WITH A PROXIMAL BORDER TO THE SUPRARENAL SEGMENT OF THE INFERIOR VENA CAVA IN A FEMALE PATIENT WITH ANKYLOSING SPONDYLITIS AND ULCERATIVE COLITIS
https://doi.org/10.14412/1995-4484-2020-336-339
Abstract
In addition to damage to the spine and joints in ankylosing spondylitis (AS), as in other diseases from a group of spondyloarthritides (SpA), there can be the following extra-articular manifestations: inflammatory bowel disease (IBD), uveitis, psoriasis, and kidney and heart diseases. In the last decade, much attention has been paid to the association between SpA and IBD; the common pathogenetic mechanisms of these diseases have been identified. The relationship between inflammation and blood coagulation has been known since ancient times, and its evidence base is constantly expanding. Both of these processes are accompanied by platelet activation and fibrin formation. The authors present a clinical case of a female patient with the comorbidity of AS with IBD and iliocaval thrombosis.
About the Authors
D. G. Rumyantseva
V.A. Nasonova Research Institute of Rheumatology
Russian Federation
Russian Federation
Daria Rumyantseva
34A, Kashirskoe Shosse, Moscow 115522
T. M. Reshetnyak
V.A. Nasonova Research Institute of Rheumatology
Russian Federation
34A, Kashirskoe Shosse, Moscow 115522
Russian Federation
34A, Kashirskoe Shosse, Moscow 115522
T. V. Dubinina
V.A. Nasonova Research Institute of Rheumatology
Russian Federation
34A, Kashirskoe Shosse, Moscow 115522
Russian Federation
34A, Kashirskoe Shosse, Moscow 115522
M. M. Urumova
V.A. Nasonova Research Institute of Rheumatology
Russian Federation
34A, Kashirskoe Shosse, Moscow 115522
Russian Federation
34A, Kashirskoe Shosse, Moscow 115522
References
1. Эрдес ШФ, Бадокин ВВ, Бочкова АГ и др. О терминологии спондилоартритов. Научно-практическая ревматология. 2015;53(6):657-60. doi: 10.14412/1995-4484-2015-657-660 [Erdes ShF, Badokin VV, Bochkova AG, et al. On the terminology of spondyloarthritis. Nauchno-Prakticheskaya Revmatologiya = Rheumatology Science and Practice. 2015;53(6):657-60. doi: 10.14412/1995-4484-2015-657-660 (In Russ.)].
2. Каратеев АЕ, Галушко ЕА. Поражение кишечника у больных спондилоартритами. Научно-практическая ревматология. 2015;53(2):190-9. [Karateev AE, Galushko EA. Bowel involvement in patients with spondyloarthritis. Nauchno-Prakticheskaya Revmatologiya = Rheumatology Science and Practice. 2015;53(2):190-9. doi: 10.14412/1995-4484-2015-190-199 (In Russ.)].
3. Ивашкин ВТ, Маев ИВ, Шульпекова ЮО и др. Клинические рекомендации Российской гастроэнтерологической ассоциации по диагностике и лечению дискинезии желчевыводящих путей. Российский журнал гастроэнтерологии, гепатологии, колопроктологии. 2018;28(3):63-80. doi: 10.22416/1382-4376-2018-28-3-63-80 [Ivashkin VT, Mayev IV, Shulpekova YuO, et al. Diagnostics and treatment of biliary dyskinesia: clinical guidelines of the Russian Gastroenterological Association. Rossiyskiy Zhurnal Gastroenterologii, Gepatologii, Koloproktologii = Rus J Gastroenterol Hepatol Coloproctol. 2018;28(3):63-80. doi: 10.22416/1382-4376-2018-28-3-63-80 (In Russ.)].
4. Levi M, van der Poll T, Buller HR. Bidirectional relation between inflammation and coagulation. Circulation. 2004 Jun 8;109(22):2698-704. doi: 10.1161/01.CIR.0000131660.51520.9A
5. Xu J, Lupu F, Esmon CT. Inflammation, innate immunity and blood coagulation. Hamostaseologie. 2010;30(5-6):8-9. doi: 10.1055/s-0037-1617146
6. Чельдиева ФА, Решетняк ТМ. Ревматоидный артрит: некоторые компоненты гемостаза и воспаление. Современная ревматология. 2019;13(3):87-94. doi: 10.14412/1996-7012-2019-3-87-94 [Cheldieva FA, Reshetnyak TM. Rheumatoid arthritis: some components of hemostasis and inflammation. Sovremennaya Revmatologiya = Modern Rheumatology Journal. 2019;13(3):87-94. doi: 10.14412/1996-7012-2019-3-87-94 (In Russ.)].
7. Westerweel PE, Verhaar MC. Endothelial progenitor cell dysfunction in rheumatic disease. Nat Rev Rheumatol. 2009 Jun;5(6):332-40. doi: 10.1038/nrrheum.2009.81
8. Zö ller B, Li X, Sundquist J, et al. Autoimmune diseases and venous thromboembolism: a review of the literature. Am J Cardiovasc Dis. 2012;2(3):171-83.
9. Ramagopalan SV, Wotton CJ, Handel AE, et al. Risk of venous thromboembolism in people admitted to hospital with selected immune-mediated diseases record-linkage study. BMC Med. 2011;9:1-8. doi: 10.1186/1741-7015-9-1
10. Zö ller B, Li X, Sundquist K. Risk of pulmonary embolism in patients with autoimmune disorders a nationwide follow-up study from Sweden. Lancet. 2012;379:244-9. doi: 10.1016/S0140-6736(11)61306-8
11. Loof TG, Schmidt O, Herwald H, et al. Coagulation systems of invertebrates and vertebrates and their roles in innate immunity: the same side of two coins? J Innate Immun. 2011;3(1):34-40. doi: 10.1159/000321641
12. Esmon CT, Esmon NL. The link between vascular features and thrombosis. Annu Rev Physiol. 2011;73:503-14. doi: 10.1146/annurev-physiol-012110-142300
13. Струкова СМ. Основы физиологии гемостаза. Учебное пособие. 2-е изд., перераб. и доп. Москва: Изд-во МГУ; 2013. С. 148-84. [Strukova SM. Osnovy fiziologii gemostaza. Uchebnoe posobie [The basics of the physiology of hemostasis. Tutorial]. 2nd ed. Moscow: MGU Publishing House; 2013. P. 148-84 (In Russ.)].
14. Esmon CT. The interactions between inflammation and coagulation. Br J Haematol. 2005;131:417-30. doi: 10.1111/j.1365-2141.2005.05753.x
15. Haroon NN, Paterson JM, Li P, et al. Patients with ankylosing spondylitis have increased cardiovascular and cerebrovascular mortality: a population-based study. Ann Intern Med. 2015;163:409-16. doi: 10.7326/M14-2470
16. Papagoras C, Voulgari PV, Drosos AA. Atherosclerosis and cardiovascular disease in the spondyloarthritides, particularly ankylosing spondylitis and psoriatic arthritis. Clin Exp Rheumatol. 2013;31:612-20.
17. Peters MJL, van EIJK IC, Smulders YVOM, et al. Signs of accelerated preclinical atherosclerosis in patients with ankylosing spondylitis. J Rheumatol. 2010;37:161-6. doi: 10.3899/jrheum.090667
18. Szabo SM, Levy AR, Rao SR, et al. Increased risk of cardiovascular and cerebrovascular diseases in individuals with ankylosing spondylitis: a population-based study. Arthritis Rheum. 2011;63:3294-304. doi: 10.1002/art.30581
19. Bengtsson K, Forsblad-d’Elia H, Lie E, et al. Are ankylosing spondylitis, psoriatic arthritis and undifferentiated spondyloarthritis associated with an increased risk of cardiovascular events? A prospective nationwide population-based cohort study. Arthritis Res Ther. 2017;19:102. doi: 10.1186/s13075-017-1315-z
20. Avina-Zubieta JA, Chan J, de Vera M, et al. Risk of venous thromboembolism in ankylosing spondylitis: a general population-based study. Ann Rheum Dis. 2019;78(4):480-5. doi: 10.1136/annrheumdis-2018-214388
21. Korswagen LA, Bertelds GM, Krieckaert CLM, et al. Venous and arterial thromboembolic events in adalimumab-treated patients with antiadalimumab antibodies. Arthritis Rheum. 2011 Apr;63(4):877-83. doi: 10.1002/art.30209
Review
For citations:
Rumyantseva D.G., Reshetnyak T.M., Dubinina T.V., Urumova M.M. ILIOCAVAL THROMBOSIS WITH A PROXIMAL BORDER TO THE SUPRARENAL SEGMENT OF THE INFERIOR VENA CAVA IN A FEMALE PATIENT WITH ANKYLOSING SPONDYLITIS AND ULCERATIVE COLITIS. Rheumatology Science and Practice. 2020;58(3):336-339. (In Russ.) https://doi.org/10.14412/1995-4484-2020-336-339
Views:
468
Email this article 